The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
T helper cells that produce interleukin 17 (IL-17) are associated with inflammation and the control of certain bacteria. We report here the essential involvement of the adaptor protein Act1 in IL-17 receptor (IL-17R) signaling and IL-17-dependent immune responses. After stimulation with IL-17, recruitment of Act1 to IL-17R required the IL-17R conserved cytoplasmic 'SEFIR' domain, followed by recruitment of the kinase TAK1 and E3 ubiquitin ligase TRAF6, which mediate 'downstream' activation of transcription factor NF-kappaB. IL-17-induced expression of inflammation-related genes was abolished in Act1-deficient primary astroglial and gut epithelial cells. This reduction was associated with much less inflammatory disease in vivo in both autoimmune encephalomyelitis and dextran sodium sulfate-induced colitis. Our data show that Act1 is essential in IL-17-dependent signaling in autoimmune and inflammatory disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The initial event in IL-17R signaling is recruitment of Act1 (aka CIKS), a multifunctional signaling protein that also contains a SEFIR domain necessary for IL-17R-Act1 association”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
In the citing paper
“upon IL-17 signaling, Act1 rapidly recruits and ubiquitinates TNF-receptor associated factor (TRAF)6”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
In the citing paper
“Act1 is best understood as a nonredundant activator of IL-17RA-dependent signals”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
In the citing paper
“TRAF6 also promotes activation of MAPK/AP1 pathways and the C/EBPβ and δ transcription factors”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521 · cited 1×
“Because IL-17 has a critical function in neutrophilia through the upregulation of chemokines, which is important for the development of inflammatory diseases including coliti”
BackgroundDong, Y., & Benveniste, E. N. (2001) · Glia · doi:10.1002/glia.1107 · Cited by 1,293 · cited 1×
“Because astrocytes are responsive to IL-17 and are important in the production of cytokines and chemokines during EA”
BackgroundTRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267
Research works printed but not linked: 13
- Mangan, P.R. et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 441, 231–234 (2006). · DOI · Paper page
- Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467–476 (2004). · DOI · Paper page
- Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubuser, A. & Eisenhaber, F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 28, 226–229 (2003). · DOI · Paper page
- Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). · DOI · Paper page
- Iwakura, Y. & Ishigame, H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116, 1218–1222 (2006). · DOI · Paper page
- Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467–476 (2004). · DOI · Paper page
- Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). · DOI · Paper page
- Weaver, A. et al. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J. 19, 1668–1670 (2005). · DOI · Paper page
- Becher, B., Bechmann, I. & Greter, M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J. Mol. Med. 84, 532–543 (2006). · DOI · Paper page
- Gold, R., Linington, C. & Lassmann, H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953–1971 (2006). · DOI · Paper page
- Koenders, M.I. et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum. 52, 3239–3247 (2005). · DOI · Paper page
- Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). · DOI · Paper page
- Han, Y., Wang, J., Zhou, Z. & Ransohoff, R.M. TGFβ1 selectively up-regulates CCR1 expression in primary murine astrocytes. Glia 30, 1–10 (2000). · DOI · Paper page
Cited by
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
“The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.”
BackgroundNeuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Kwon, H. S., & Koh, S.-H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00221-2 · Cited by 2,595
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
Ouyang, W., Kolls, J. K., & Zheng, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.004 · Cited by 1,700
“Indeed , Act1 binds to the cytoplasmic domain of IL-17RA (Chang et al., 2006b) and is a functional adaptor critical for IL-17RA signaling and the development of EAE and dextran-sodium-sulfateinduced colitis (Qian et al., 2007).”
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
“Co-immunoprecipitation studies indicate that ACT1 is recruited to IL-17RA within 5 minutes of IL-17A stimulatio”
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“TRAF6 also promotes activation of MAPK/AP1 pathways and the C/EBPβ and δ transcription factors (Chang et al., 2006; Maitra et al., 2007; Qian et al., 2007; Ruddy et al., 2004).”
BackgroundInfluentialTargeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
TH17 cells in development: an updated view of their molecular identity and genetic programming
Dong, C. (2008) · Nature reviews. Immunology · doi:10.1038/nri2295 · Cited by 1,064
“ACT1-deficient mice were resistant to experimental autoimmune encephalomyelitis (EAE), as well as colitis induced by dextran sulphate sodium (DSS”
BackgroundGenetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2 (2010) · Nature Genetics · doi:10.1038/ng.694 · Cited by 1,047
“Of these genes, TRAF3IP2 encodes ACT1, an adaptor protein essential for IL17-dependent NF-κB activation and Th17-mediated inflammatory response”
BackgroundIL-17 and IL-17-producing cells in protection versus pathology
Mills, K. H. G. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00746-9 · Cited by 1,000
Astrocyte Crosstalk in CNS Inflammation
Linnerbauer, M., Wheeler, M. A., & Quintana, F. J. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.012 · Cited by 989
“Nuclear translocation of NF-κB in astrocytes is triggered by pro-inflammatory stimuli such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-17 (Qian et al., 2007), reactive oxygen species (ROS) (Chandel et al.”
BackgroundInfluentialAstrocytes: Key Regulators of Neuroinflammation
Colombo, E., & Farina, C. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.06.006 · Cited by 904
“IL17 binding to heteromeric transmembrane receptors results in the recruitment of NFkB activator 1 (Act1) and formation of a signaling complex which triggers the production of pro-inflammatory cytokines, chemokines and metalloproteinases [36].”
BackgroundInterleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
Evidence for a cross-talk between human neutrophils and Th17 cells
Pelletier, M., Maggi, L., Micheletti, A., Lazzeri, E., Tamassia, N., Costantini, C., Cosmi, L., Lunardi, C., Annunziato, F., Romagnani, S., et al. (2010) · Blood · doi:10.1182/blood-2009-04-216085 · Cited by 782
“Act1 is an essential component of the IL-17-dependent signaling pathway that ultimately drives the induction of cytokine and chemokine gene expression.(28) For this reason, we established that, in human neutrophils, Act1 is not only expressed at the mRNA (Fig.”
BackgroundIL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
Lee, J. S., Tato, C. M., Joyce-Shaikh, B., Gulen, M. F., Cayatte, C., Chen, Y., Blumenschein, W. M., Judo, M., Ayanoglu, G., McClanahan, T. K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.003 · Cited by 760
“K18creAct1 mice were provided by Xiaoxia Li and have been described previously (Qian et al., 2007; Swaidani et al., 2009) All animal procedures were approved by the Institutional Animal Care and Use Committee of Merck Research Laboratories in accordance with guidelines of the Association for Assessment and Accreditati…”
InfluentialSelf-citationThe cytokine network involved in the host immune response to periodontitis
Pan, W., Wang, Q., & Chen, Q. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0064-z · Cited by 696
IL-17 family: Cytokines, receptors and signaling
Gu, C., Wu, L., & Li, X. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.022 · Cited by 595
“deficient in IL-17-signaling exhibited attenuated disease severity compared to wild-type controls [47, 93].”
BackgroundSelf-citationIL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
Self-citationIL-17 cytokines in immunity and inflammation
Jin, W., & Dong, C. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.58 · Cited by 529
The roles of IL‐17A in inflammatory immune responses and host defense against pathogens
Iwakura, Y., Nakae, S., Saijo, S., & Ishigame, H. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00699.x · Cited by 513
The Role of IL-17 and related cytokines in inflammatory autoimmune diseases
Kuwabara, T., Ishikawa, F., Kondo, M., & Kakiuchi, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/3908061 · Cited by 519
“Through the analysis of the function of Th17 cells in autoimmune diseases, there has been significant progress in the understanding of the biological significance of IL-17.”
BackgroundThe IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
“Activation of the TAK1 complex is necessary for the recruitment and activation of the NF-κB kinase inhibitor (IKK) complex composed of IKKα, IKKβ, and IKKγ/NEMO subunits.(35,36,49) IKK then phosphorylates the NF-κB subunits, and the labeled IκB is hydrolyzed by protease enzymes to expose NF-κB’s nuclear localization s…”
BackgroundResultCooke, K. R., Luznik, L., Sarantopoulos, S., Hakim, F. T., Jagasia, M., Fowler, D. H., van den Brink, M. R. M., Hansen, J. A., Parkman, R., Miklos, D. B., et al. (2017) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2016.09.023 · Cited by 472
“IL-17 is mechanistically linked to skin and lung GVHD in mice [133-135].”
BackgroundTRAF molecules in cell signaling and in human diseases
Xie, P. (2013) · Journal of Molecular Signaling · doi:10.1186/1750-2187-8-7 · Cited by 466
“Activated NF-κB further induces the expression of IkBζ, C/EBPδ and C/EBPβ, transcription factors that work in concert with NF-κB to induce the expression of signature target genes of IL-17 [12,147,154-158].”
BackgroundTh17 cells: Effector T cells with inflammatory properties
Korn, T., Oukka, M., Kuchroo, V., & Bettelli, E. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.007 · Cited by 445
“The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.”
BackgroundElias, K. M., Laurence, A., Davidson, T. S., Stephens, G., Kanno, Y., Shevach, E. M., & O'Shea, J. J. (2008) · Blood · doi:10.1182/blood-2007-06-096438 · Cited by 448
Zhu, S., Pan, W., Song, X., Liu, Y., Shao, X., Tang, Y., Liang, D., He, D., Wang, H., Liu, W., et al. (2012) · Nature Medicine · doi:10.1038/nm.2815 · Cited by 396
Self-citationTaylor, P. R., Roy, S., Leal, S. M., Sun, Y., Howell, S. J., Cobb, B. A., Li, X., & Pearlman, E. (2014) · Nature Immunology · doi:10.1038/ni.2797 · Cited by 410
Self-citationThe IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
Liu, T., Li, S., Ying, S., Tang, S., Ding, Y., Li, Y., Qiao, J., & Fang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594735 · Cited by 386
“org 2 downstream signaling cascades by tumor-necrosis factor receptor–associated factor (TRAF) 6 (28).”
BackgroundAn overview of IL-17 function and signaling
Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.017 · Cited by 382
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis
Hüffmeier, U., Uebe, S., Ekici, A. B., Bowes, J., Giardina, E., Korendowych, E., Juneblad, K., Apel, M., McManus, R., Ho, P., et al. (2010) · Nature Genetics · doi:10.1038/ng.688 · Cited by 371
“Studies of TRAF3IP2-deficient mice suggest that Act1 is a negative regulator of humoral immunity through its inhibitory effect on CD40- and BAFFR-mediated signalin”
BackgroundGenome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2
Ellinghaus, E., Ellinghaus, D., Stuart, P. E., Nair, R. P., Debrus, S., Raelson, J. V., Belouchi, M., Fournier, H., Reinhard, C., Ding, J., et al. (2010) · Nature Genetics · doi:10.1038/ng.689 · Cited by 359
“The gene product of TRAF3IP2 is a positive signaling adaptor required for IL-17–mediated T-cell immune response”
BackgroundInterleukin-17 and its expanding biological functions
Xu, S., & Cao, X. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.21 · Cited by 357
Identification of the IL-17 Receptor Related Molecule IL-17RC as the Receptor for IL-17F
Kuestner, R. E., Taft, D. W., Haran, A., Brandt, C. S., Brender, T., Lum, K., Harder, B., Okada, S., Ostrander, C. D., Kreindler, J. L., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5462 · Cited by 352
Alcorn, J. F., Crowe, C. R., & Kolls, J. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135926 · Cited by 348
Monin, L., & Gaffen, S. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028522 · Cited by 339
“On cytokine ligation, the IL-17 receptor complex is thought to undergo a conformational change enabling the establishment of homotypic interactions between the SEFIR domains of the receptor and the signaling adaptor Act1 (Qian et al. 2007).”
BackgroundThe role of IL-17 in CNS diseases
Waisman, A., Hauptmann, J., & Regen, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1402-7 · Cited by 340
“Following engagement of the IL-17RA/C complex by one of the above IL-17 molecules, the adaptor protein Act1 is recruited to the SEFIR domain in the receptor complex, resulting in the consecutive recruitment of TAK1 and E3 ubiquitin ligase TRAF6, which mediate activation of the transcription factor NF-κB [72] (Fig.”
BackgroundTh17 cells and mucosal host defense
Aujla, S. J., Dubin, P. J., & Kolls, J. K. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.009 · Cited by 304
“Recently it has been demonstrated that in mouse embryonic fibroblasts the induction of CXCL1 by IL-17A and IL-17F requires the downstream adaptor Act1 and the induction of CXCL1 is only partly dependent on NF-κB [32].”
BackgroundSelected cytokine pathways in rheumatoid arthritis
Noack, M., & Miossec, P. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0619-z · Cited by 303
“This induces the oligomerization and the activation of TRAF6 that leads to the activation of the transcription factors NFκB and activator protein 1 (AP-1).”
BackgroundInfluentialSong, X., Zhu, S., Shi, P., Liu, Y., Shi, Y., Levin, S. D., & Qian, Y. (2011) · Nature Immunology · doi:10.1038/ni.2155 · Cited by 312
Self-citationKang, Z., Altuntas, C. Z., Gulen, M. F., Liu, C., Giltiay, N., Qin, H., Liu, L., Qian, W., Ransohoff, R. M., Bergmann, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.004 · Cited by 297
“Importantly, activated MOG 35-55-specific Th1 (Qian et al., 2007) and Th17 cells derived from primed Act1 / mice were both fully encephalitogenic because they were able to passively transfer EAE in wild-type recipients (Figures 2B–2D; 416 Immunity 32, 414–425, March 26, 2010 ª2010 Elsevier…”
InfluentialSelf-citationBoisson, B., Wang, C., Pedergnana, V., Wu, L., Cypowyj, S., Rybojad, M., Belkadi, A., Picard, C., Abel, L., Fieschi, C., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.002 · Cited by 293
“In both mice (Qian et al., 2007) and humans (this report), ACT1 deficiency leads to expansion of IL-17- and IL-22-producing T cell populations.”
InfluentialSelf-citationHuang, H., Kim, H. J., Chang, E.-J., Lee, Z. H., Hwang, S. J., Kim, H.-M., Lee, Y., & Kim, H.-H. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.74 · Cited by 272
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Zhu, S., & Qian, Y. (2012) · Clinical Science · doi:10.1042/cs20110496 · Cited by 282
Self-citationRecent advances in the IL-17 cytokine family
Gaffen, S. L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.006 · Cited by 283
“This signal is Act1-dependent, but occurs in the absence of TRAF6 [79].”
IL-17 Enhances Chemokine Gene Expression through mRNA Stabilization
Hartupee, J., Liu, C., Novotny, M., Li, X., & Hamilton, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4135 · Cited by 282
Self-citationInterleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor E
Chang, S. H., Reynolds, J. M., Pappu, B. P., Chen, G., Martinez, G. J., & Dong, C. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.010 · Cited by 271
“In the current study, we have found that a cytokine-cytokine receptor pair, IL-17C and IL-17RE, regulates inflammatory disease and promotes Th17 cell differentiation (via signaling components IL-17RA and Act1) and induction of IkBz.”
InfluentialThe role of cytokines in inflammatory bone loss
Souza, P. P. C., & Lerner, U. H. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.822766 · Cited by 269
“The production of proinflammatory cytokines induced by intraperiotoneal IL-17 injection in vivo was completely abolished in Act1-/- mice (Qian et al., 2007).”
BackgroundInfluentialTh17 cytokines and mucosal immunity
Dubin, P. J., & Kolls, J. K. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00703.x · Cited by 244
“Moreover, Act1 / mice are protected against the development of experimental autoimmune encephalitis and dextran sodium sulfate-induced colitis (26).”
BackgroundShen, F., & Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.013 · Cited by 256
“[149] Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, et al.”
BackgroundResultInfluentialThe role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 248
Self-citationTakedatsu, H., Michelsen, K. S., Wei, B., Landers, C. J., Thomas, L. S., Dhall, D., Braun, J., & Targan, S. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.037 · Cited by 254
Clonal expansion in non-cancer tissues
Kakiuchi, N., & Ogawa, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00335-3 · Cited by 252
Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage
Song, X., Dai, D., He, X., Zhu, S., Yao, Y., Gao, H., Wang, J., Qu, F., Qiu, J., Wang, H., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.024 · Cited by 243
Self-citationBrown, K. D., Claudio, E., & Siebenlist, U. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2457 · Cited by 245
IL-17 family member cytokines: Regulation and function in innate immunity
Reynolds, J. M., Angkasekwinai, P., & Dong, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.002 · Cited by 235
“The cytokines IL-17 and IL-17F employ the adaptors TRAF6 and Act1 in their signaling transduction pathways as well(27,28).”
BackgroundIL-17 and IL-22: siblings, not twins
Eyerich, S., Eyerich, K., Cavani, A., & Schmidt-Weber, C. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.06.004 · Cited by 236
Sun, D., Novotny, M., Bulek, K., Liu, C., Li, X., & Hamilton, T. (2011) · Nature Immunology · doi:10.1038/ni.2081 · Cited by 232
Self-citationIL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Zepp, J., Wu, L., & Li, X. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.007 · Cited by 224
Self-citationAct1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling
Liu, C., Qian, W., Qian, Y., Giltiay, N. V., Lu, Y., Swaidani, S., Misra, S., Deng, L., Chen, Z. J., & Li, X. (2009) · Science Signaling · doi:10.1126/scisignal.2000382 · Cited by 224
“Whereas the SEFIR domain is an interaction domain, the U-box domain of Act1 is an effector domain required for Act1 to transduce signals from the IL-17R.”
BackgroundMethodInfluentialSelf-citationWu, L., Chen, X., Zhao, J., Martin, B., Zepp, J. A., Ko, J. S., Gu, C., Cai, G., Ouyang, W., Sen, G., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150204 · Cited by 221
Self-citationAct1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells
Kang, Z., Wang, C., Zepp, J., Wu, L., Sun, K., Zhao, J., Chandrasekharan, U., DiCorleto, P. E., Trapp, B. D., Ransohoff, R. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3505 · Cited by 218
Self-citationGenetics of spondyloarthritis—beyond the MHC
Reveille, J. D. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.41 · Cited by 202
Adverse functions of IL‐17A in experimental sepsis
Flierl, M. A., Rittirsch, D., Gao, H., Hoesel, L. M., Nadeau, B. A., Day, D. E., Zetoune, F. S., Sarma, J. V., Huber-Lang, M. S., Ferrara, J. L. M., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-105221 · Cited by 203
“The requirement of Act-1 for IL-17A and IL-17A receptor (IL-17RA) -dependent signaling during the immune response has been confirmed in other studies (40, 41).”
Zhong, B., Liu, X., Wang, X., Chang, S. H., Liu, X., Wang, A., Reynolds, J. M., & Dong, C. (2012) · Nature Immunology · doi:10.1038/ni.2427 · Cited by 206
The activation and regulation of IL-17 receptor mediated signaling
Song, X., & Qian, Y. (2013) · Cytokine · doi:10.1016/j.cyto.2013.03.014 · Cited by 206
Self-citationIL-17 in the lung: the good, the bad, and the ugly
Gurczynski, S. J., & Moore, B. B. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00344.2017 · Cited by 202
Gulen, M. F., Kang, Z., Bulek, K., Youzhong, W., Kim, T. W., Chen, Y., Altuntas, C. Z., Sass Bak-Jensen, K., McGeachy, M. J., Do, J.-S., et al. (2010) · Immunity · doi:10.1016/j.immuni.2009.12.003 · Cited by 199
“…CCL7, and CCL20), as well as matrix metalloproteases (MMPs) that allow activated T cells to penetrate extracellular matrix (Fossiez et al., 1996; Yao et al., 1995; Andoh et al., 2005; Laan et al., 1999; Kao et al., 2005; Chabaud et al., 2000; Bamba et al., 2003; Gaffen, 2008; Qian et al., 2007).”
BackgroundMethodSelf-citationEffects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes
Hot, A., & Miossec, P. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143768 · Cited by 201
“Thus, the net effect of IL-17A and IL-17F signalling is to enhance an innate-type inflammatory gene expression programme that mediates potent inflammation response and plays a key role in host defense.”
BackgroundCheung, P. F. Y., Wong, C. K., & Lam, C. W. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5625 · Cited by 200
“IL-17A and IL-17F are members of the IL-17 family that play crucial roles in allergic inflammation.”
BackgroundInfluentialZhang, J., Wang, D., Wang, L., Wang, S., Roden, A. C., Zhao, H., Li, X., Prakash, Y. S., Matteson, E. L., Tschumperlin, D. J., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00301.2018 · Cited by 194
“The IL-17A/IL-17RA axis has been reported to signal through the activation of NF- B as well as other pathways (13, 23, 52, 69).”
BackgroundSelf-citationEnhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci
Tsoi, L. C., Spain, S. L., Ellinghaus, E., Stuart, P. E., Capon, F., Knight, J., Tejasvi, T., Kang, H. M., Allen, M. H., Lambert, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8001 · Cited by 195
Structural basis of receptor sharing by interleukin 17 cytokines
Ely, L. K., Fischer, S., & Garcia, K. C. (2009) · Nature Immunology · doi:10.1038/ni.1813 · Cited by 195
“However, IL-17 receptor signaling does not use the same set of membrane-proximal adaptor molecules as Toll-like receptor signaling does; IL-17R requires the adaptor Act1, which also contains a SEF–IL-17R domai”
BackgroundRole of SMAD and Non-SMAD Signals in the Development of Th17 and Regulatory T Cells
Lu, L., Wang, J., Zhang, F., Chai, Y., Brand, D., Wang, X., Horwitz, D. A., Shi, W., & Zheng, S. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903418 · Cited by 191
“Th17 cells play an important role in host defense; however, IL-17 produced by Th17 cells is also crucial for chronic inflammation in many disease models, such as EAE and colitis (51, 52).”
Interleukin-17 enhances immunosuppression by mesenchymal stem cells
Han, X., Yang, Q., Lin, L., Xu, C., Zheng, C., Chen, X., Han, Y., Li, M., Cao, W., Cao, K., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.85 · Cited by 189
“Upon IL-17 binding, IL-17RA recruits Act1, a critical downstream mediator of the IL-17-induced signaling process.(9,10) Although much is known about the IL-17-induced signaling pathways, its cellular targets and mode of action during inflammatory processes and autoimmune diseases”
BackgroundSelf-citationBulek, K., Liu, C., Swaidani, S., Wang, L., Page, R. C., Gulen, M. F., Herjan, T., Abbadi, A., Qian, W., Sun, D., et al. (2011) · Nature Immunology · doi:10.1038/ni.2080 · Cited by 192
Self-citationIL‐17: overview and role in oral immunity and microbiome
Abusleme, L., & Moutsopoulos, N. (2017) · Oral Diseases · doi:10.1111/odi.12598 · Cited by 183
“Engagement of IL-17 (IL-17A, IL-17F and IL-17A/F) to the IL-17R heterodimeric complex, leads to the association of the adaptor protein Act1 (previously named CIKS) through the SEFIR domain (Qian et al., 2007).”
Targeted Immunotherapy for Autoimmune Disease
Jung, S. M., & Kim, W.-U. (2022) · Immune Network · doi:10.4110/in.2022.22.e9 · Cited by 171
“Upon binding with IL-17A, a unique intracellular cytoplasmic domain termed SEF/IL-17R of IL-17R subunit A (IL17RA) and subunit C (IL-17RC) recruit the adaptor protein Act1, which triggers ubiquitination of TNF-receptor associated factor (TRAF) 6 and subsequent activation of the NF-κB, MAPK, and activator protein 1 (AP…”
BackgroundThe TLR and IL-1 signalling network at a glance
Cohen, P. (2014) · Journal of Cell Science · doi:10.1242/jcs.149831 · Cited by 181
“However, in the IL-17 signalling network, where TRAF6 is also an essential protein, ACT1 and not TRAF6 is thought to be the E3 ligase that generates the K63-pUb chains needed to switch on TAK1, with TRAF6 functioning as a coupling factor in this process (Qian et al., 2007).”
BackgroundKaiser, P., Diard, M., Stecher, B., & Hardt, W. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01070.x · Cited by 181
Interleukin-17: A novel inflammatory cytokine that bridges innate and adaptive immunity
Yu, J. (2008) · Frontiers in Bioscience · doi:10.2741/2667 · Cited by 178
“Act1 then leads to the recruitment of the kinase TAK1 and E3 ubiquitin ligase TNF-Receptor Associated Factor 6 (TRAF6) to activate NF-kappaB (36, 38, 39).”
BackgroundInfluentialIL-17F: Regulation, signaling and function in inflammation
Chang, S. H., & Dong, C. (2009) · Cytokine · doi:10.1016/j.cyto.2008.12.024 · Cited by 169
Harada, K., Shimoda, S., Sato, Y., Isse, K., Ikeda, H., & Nakanuma, Y. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03947.x · Cited by 180
Peric, M., Koglin, S., Kim, S.-M., Morizane, S., Besch, R., Prinz, J. C., Ruzicka, T., Gallo, R. L., & Schauber, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8504 · Cited by 174
“Act1 has recently been shown in vivo to be essential for IL-17A-mediated inflammation in the brain during experimental autoimmune encephalomyelitis and in gut epithelial cells during induced colitis (28).”
BackgroundIL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms
Ha, H.-L., Wang, H., Pisitkun, P., Kim, J.-C., Tassi, I., Tang, W., Morasso, M. I., Udey, M. C., & Siebenlist, U. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400513111 · Cited by 171
“heterotypic SEFIR domain association (22, 23).”
The Potential Role of Interleukin-17 in Severe Asthma
Wang, Y.-H., & Wills-Karp, M. (2011) · Current Allergy and Asthma Reports · doi:10.1007/s11882-011-0210-y · Cited by 171
“The signaling adaptor ACT1, which also contains the SEFIR domain, is essential for mediating IL-17R signaling [21].”
BackgroundLévy, R., Okada, S., Béziat, V., Moriya, K., Liu, C., Chai, L. Y. A., Migaud, M., Hauck, F., Al Ali, A., Cyrus, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618300114 · Cited by 174
Self-citationInterleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis
Pisitkun, P., Ha, H.-L., Wang, H., Claudio, E., Tivy, C. C., Zhou, H., Mayadas, T. N., Illei, G. G., & Siebenlist, U. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.014 · Cited by 174
“Consistent with a role for IL-17 cytokines in disease, the CIKS (Traf3ip2; Act1) adaptor is essential for development of CIA and EAE (Pisitkun et al., 2010; Qian et al., 2007).”
IL-23 and Th17 cytokines in intestinal homeostasis
Maloy, K. J., & Kullberg, M. C. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.28 · Cited by 166
Maitra, A., Shen, F., Hanel, W., Mossman, K., Tocker, J., Swart, D., & Gaffen, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611589104 · Cited by 165
IL-25 (IL-17E) in epithelial immunology and pathophysiology
Borowczyk, J., Shutova, M., Brembilla, N. C., & Boehncke, W.-H. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.12.628 · Cited by 158
IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases
Song, X., & Qian, Y. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.07.021 · Cited by 162
Self-citationAnti-Inflammatory Activities of Marine Algae in Neurodegenerative Diseases
Barbalace, M. C., Malaguti, M., Giusti, L., Lucacchini, A., Hrelia, S., & Angeloni, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123061 · Cited by 160
“During neuroinflammation, NF-κB signaling is also stimulated in astrocytes [59], where its translocation to the nucleus and the subsequent cytokines expression is triggered by IL-17-receptor [60] and lactosyl ceramide, a lipid mediator produced by astrocytes [61].”
BackgroundHou, W., Jin, Y.-H., Kang, H. S., & Kim, B. (2014) · Journal of Virology · doi:10.1128/jvi.00724-14 · Cited by 174
“IL-17 signaling utilizes JAK2 for STAT3 phosphorylation and Act1/TRAF6 for NF- B activation (34, 43).”
IL-17 in the immunopathogenesis of spondyloarthritis
Taams, L. S., Steel, K. J. A., Srenathan, U., Burns, L. A., & Kirkham, B. W. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0044-2 · Cited by 158
T cell–intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis
Martin, B. N., Wang, C., Zhang, C.-J., Kang, Z., Gulen, M. F., Zepp, J. A., Zhao, J., Bian, G., Do, J.-S., Min, B., et al. (2016) · Nature Immunology · doi:10.1038/ni.3389 · Cited by 155
Self-citationInterleukin-17A: The Key Cytokine in Neurodegenerative Diseases
Chen, J., Liu, X., & Zhong, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.566922 · Cited by 164
Hu, Y., Ota, N., Peng, I., Refino, C. J., Danilenko, D. M., Caplazi, P., & Ouyang, W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903614 · Cited by 153
Metadata
- Authors
- Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., Kordula, T., Zhang, Q.-W., Vallance, B., Swaidani, S., Aronica, M., Tuohy, V. K., Hamilton, T., & Li, X.
- Affiliations
- Cleveland Clinic (US)
- Case Western Reserve University (US)
- Virginia Commonwealth University (US)
- University of British Columbia (CA)
- Corresponding author
- Li, Xiaoxia
- ORCID
- Venue
- Nature Immunology
- Published
- 2007-02-04
- Volume
- 8
- Issue
- 3
- Pages
- 247-256
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2021674244
- Cited by
- 614
- References
- 45
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 34 · 2023: 32 · 2022: 37 · 2021: 41 · 2020: 23 · 2019: 30 · 2018: 25 · 2017: 25 · 2016: 21 · 2015: 26 · 2014: 31 · 2013: 38 · 2012: 33
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI065470, AI 065470)
- National Institute of Neurological Disorders and Stroke (R01-NS071996)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- Act1, IL-17, IL-17 receptor signaling, TAK1, TRAF6, NF-κB activation, adaptor proteins, astrocytes, intestinal epithelial cells, autoimmune encephalomyelitis, DSS-induced colitis, inflammatory diseases, T helper cells
- MeSH terms
- Animals, Autoimmune Diseases, Colitis, Encephalomyelitis, Autoimmune, Experimental, Enzyme-Linked Immunosorbent Assay, Female, Fluorescent Antibody Technique, Gene Expression Regulation, HeLa Cells, Humans, Inflammation, T-Lymphocytes, Transfection, Signal Transduction, Autoimmunity, Gene Expression, CD40 Antigens, Adoptive Transfer, Reverse Transcriptase Polymerase Chain Reaction, Interleukin-17, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Adaptor Proteins, Signal Transducing, Mice, B-Cell Activation Factor Receptor, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.